Shai S. Erlich
Direttore Tecnico/Scientifico/R&S presso Quark Pharmaceuticals, Inc.
Profilo
Shai S.
Erlich is currently the President-US Operations & Chief Medical Officer at Quark Pharmaceuticals, Inc. He started this position in 2010.
Prior to his current role, he has a background in education, having obtained a graduate degree from Tel-Aviv University, an undergraduate degree from Ben-Gurion University of the Negev, and a doctorate degree from Icahn School of Medicine at Mount Sinai.
Posizioni attive di Shai S. Erlich
Società | Posizione | Inizio |
---|---|---|
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Direttore Tecnico/Scientifico/R&S | 27/09/2010 |
Formazione di Shai S. Erlich
Ben-Gurion University of the Negev | Undergraduate Degree |
Tel-Aviv University | Graduate Degree |
Icahn School of Medicine at Mount Sinai | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Quark Pharmaceuticals, Inc.
Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Health Technology |
- Borsa valori
- Insiders
- Shai S. Erlich